HSP90AA1 and lung carcinoma: However, no previous studies have focused explicitly on the relationship between plasmatic levels of HSP90α at diagnosis and the prognosis of advanced lung cancer patients treated with PD1/PD-L1 inhibitors plus chemotherapy.